Published: 2024-08-28 Rejuvenate Bio lands $4m grant for gene-therapy research The firm’s CEO says manufacturing prices for the traditionally expensive treatments will decrease as technology improves. Picture of Josh Abbott Josh Abbott August 28, 2024 Gene-therapy developer Rejuvenate Bio was recently awarded $4 million by the California Institute for Regenerative Medicine (CIRM) to pursue investigational...Read More